BAYTRIL FLAVOUR TABLETS 250 MG
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
20-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ENROFLOXACIN
Available from:
Bayer Limited
ATC code:
QJ01MA90
Dosage:
250 Milligram
Pharmaceutical form:
Tablets
Therapeutic group:
Antibacterial
Therapeutic area:
Canine
Authorization date:
2011-07-15
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Baytril Flavour Tablets 250 mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Tablet.
Light brown to brown, slightly marbled, scored tablets for oral administration to dogs.
The tablets can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is for use in dogs in the treatment of bacterial infections of the alimentary, respiratory and urogenital
tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by
sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
4.3 CONTRAINDICATIONS
Not for use in dogs less than 1 year of age or in exceptionally large breeds of dog with a longer growth period under 18
months of age, as articular cartilage may be affected during the period of rapid growth.
Baytril Flavour Tablets 250 mg should not be used for prophylaxis.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Please see point 4.3.
Active substance
mg per tablet
Enrofloxacin
250.0
For a full list of escipients, see section 6.1.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 26/07/2011_
_CRN 7005428_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not exceed the recommended dose.
II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
None.
III) OTHER PRECAUTIONS
None.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
In dogs enrofloxacin may affect articular cartilage during the period of rapid growth.
4.7 USE DURING PREGNANCY, LACTATION O
Read the complete document
